TAM (Treatments and Medicines) app
TAM (Treatments and Medicines) app
  • Home
  • Feedback
  • About
  • Submit guidance
  • For Healthcare Professionals
  • For Patients and Carers
  • Notifications
Sign Out
  • Home
  • Feedback
  • About
  • Submit guidance
  • For Healthcare Professionals
  • For Patients and Carers
  • Notifications
  • Treatments and Medicines
  • For Healthcare Professionals
  • COVID-19 (Coronavirus)
  • Highest Risk List: COVID-19

Highest Risk List: COVID-19

What's New

19/07/22: Information about shielding has been removed and replaced with information relating to the Highest Risk List. 

Close
Previous
Next
Print
Go to algorithm
May 2022
  • CMO Letter - COVID highest risk
  • CMO Letter - COVID highest risk - Immunosuppressed
Editorial Information

Last reviewed: 19 July 2022

Next review: 31 January 2023

Version: 2

Reviewer Name(s): Alison Felce, Senior Business Manager, Medical Directorate

Document Id: COVID032

Internal URL: https://nhshighlands.azurewebsites.net/umbraco/#/content/content/edit/9824

  • For Healthcare Professionals
    • COVID-19 (Coronavirus)
      • Care and treatment pathway (COVID-19)
      • Highest Risk List: COVID-19
      • Presentation & assessment (COVID-19)
      • Testing (COVID-19)
      • Treatment (COVID-19)
      • PRIMARY CARE - COVID-19 (Community and Care Home)
      • SECONDARY CARE - COVID-19 (Community / RGH / Raigmore hospitals)
      • End of life care (COVID-19)
      • Adapted therapeutic guidelines (COVID-19)
      • Vaccine (COVID-19)
      • Long COVID
      • COVID-19: trial medication
    • THERAPEUTIC GUIDELINES
    • ANTIMICROBIAL GUIDANCE
    • FORMULARIES (and the Pink One)
    • PATIENT INFORMATION
    • FURTHER CLINICAL RESOURCES

Powered by Quris